Tissue expression
Cell line expression
Protein structure
NAT2
N-acetyltransferase 2AAC2
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second polymorphic arylamine N-acetyltransferase gene (NAT1), is located near this gene (NAT2). [provided by RefSeq, Sep 2019]
Top validated antibodies |
|||||
antibodies-online | ![]() |
12 references | Monoclonal |
|
|
Aviva Systems Biology | ![]() |
Polyclonal |
|
||
Invitrogen Antibodies | ![]() |
Polyclonal |
|
||
Abgent | ![]() |
Polyclonal |
|
||
Cusabio Biotech Co., Ltd | ![]() |
Polyclonal |
|